Table of Contents Author Guidelines Submit a Manuscript
Journal of Biomedicine and Biotechnology
Volume 2012, Article ID 456534, 7 pages
http://dx.doi.org/10.1155/2012/456534
Research Article

Overexpression of Runt-Related Transcription Factor-2 Is Associated with Advanced Tumor Progression and Poor Prognosis in Epithelial Ovarian Cancer

1Department of Gynaecology and Obstetrics, Clinical Section, PLA General Hospital, Beijing 100853, China
2Anesthesia and Operation Center, Clinical Section, PLA General Hospital, Beijing 100853, China
3Department of Gynaecology and Obstetrics, Yantaishan Hosptial, Shandong, Yantai 264000, China
4Clinical Section, PLA General Hospital, Beijing 100853, China

Received 13 May 2012; Revised 4 August 2012; Accepted 4 August 2012

Academic Editor: Andre Van Wijnen

Copyright © 2012 Weiping Li et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. J. Jordan, K. L. Cushing-Haugen, K. G. Wicklund, J. A. Doherty, and M. A. Rossing, “Breast-feeding and risk of epithelial ovarian cancer,” Cancer Causes and Control, vol. 21, no. 1, pp. 109–116, 2010. View at Google Scholar
  2. M. Rota, E. Pasquali, L. Scotti et al., “Alcohol drinking and epithelial ovarian cancer risk. A systematic review and meta-analysis,” Gynecologic Oncology, vol. 125, no. 3, pp. 758–763, 2012. View at Google Scholar
  3. M. Wang, Y. He, L. Shi, and C. Shi, “Multivariate analysis by Cox proportional hazard model on prognosis of patient with epithelial ovarian cancer,” European Journal of Gynaecological Oncology, vol. 32, no. 2, pp. 171–177, 2011. View at Google Scholar · View at Scopus
  4. N. O. Chimge, S. K. Baniwal, G. H. Little et al., “Regulation of breast cancer metastasis by RUNX2 and estrogen signaling: the role of SNAI2,” Breast Cancer Research, vol. 13, article R127, 2011. View at Google Scholar
  5. M. L. Slattery, A. Lundgreen, J. S. Herrick, B. J. Caan, J. D. Potter, and R. K. Wolff, “Associations between genetic variation in RUNX1, RUNX2, RUNX3, MAPK1 and eIF4E and risk of colon and rectal cancer: additional support for a TGF-β-signaling pathway,” Carcinogenesis, vol. 32, no. 3, pp. 318–326, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. G. H. Little, H. Noushmehr, S. K. Baniwal, B. P. Berman, G. A. Coetzee, and B. Frenkel, “Genome-wide RUNX2 occupancy in prostate cancer cells suggests a role in regulating secretion,” Nucleic Acids Research, vol. 40, pp. 3538–3547, 2012. View at Google Scholar
  7. J. W. Martin, M. Zielenska, G. S. Stein, A. J. van Wijnen, and J. A. Squire, “The role of RUNX2 in osteosarcoma oncogenesis,” Sarcoma, vol. 2011, Article ID 282745, 13 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. M. van der Deen, J. Akech, D. Lapointe et al., “Genomic promoter occupancy of runt-related transcription factor RUNX2 in Osteosarcoma cells identifies genes involved in cell adhesion and motility,” The Journal of Biological Chemistry, vol. 287, pp. 4503–4517, 2012. View at Google Scholar
  9. C. W. Chua, Y. T. Chiu, H. F. Yuen et al., “Suppression of androgen-independent prostate cancer cell aggressiveness by FTY720: validating Runx2 as a potential antimetastatic drug screening platform,” Clinical Cancer Research, vol. 15, no. 13, pp. 4322–4335, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Pratap, A. Javed, L. R. Languino et al., “The Runx2 osteogenic transcription factor regulates matrix metalloproteinase 9 in bone metastatic cancer cells and controls cell invasion,” Molecular and Cellular Biology, vol. 25, no. 19, pp. 8581–8591, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. H. Kayed, X. Jiang, S. Keleg et al., “Regulation and functional role of the Runt-related transcription factor-2 in pancreatic cancer,” British Journal of Cancer, vol. 97, no. 8, pp. 1106–1115, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. T. Sase, T. Suzuki, K. Miura et al., “Runt-related transcription factor 2 in human colon carcinoma: a potent prognostic factor associated with estrogen receptor,” International Journal of Cancer. In press.
  13. L. Dalle Carbonare, A. Frigo, G. Francia et al., “Runx2 mRNA expression in the tissue, serum, and circulating non-hematopoietic cells of patients with thyroid cancer,” The Journal of Clinical Endocrinology & Metabolism, vol. 97, no. 7, pp. E1249–E1256, 2012. View at Google Scholar
  14. M. Tandon, K. Gokul, S. A. Ali et al., “RUNX2 mediates epigenetic silencing of the bone morphogenetic protein-3B (BMP-3B/GDF10) in lung cancer cells,” Molecular Cancer, vol. 11, article 27, 2012. View at Google Scholar
  15. K. Y. Won, H. R. Park, and Y. K. Park, “Prognostic implication of immunohistochemical Runx2 expression in osteosarcoma,” Tumori, vol. 95, no. 3, pp. 311–316, 2009. View at Google Scholar · View at Scopus
  16. Y. Onodera, Y. Miki, T. Suzuki et al., “Runx2 in human breast carcinoma: its potential roles in cancer progression,” Cancer Science, vol. 101, no. 12, pp. 2670–2675, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. K. Blyth, F. Vaillant, A. Jenkins et al., “Runx2 in normal tissues and cancer cells: a developing story,” Blood Cells, Molecules, and Diseases, vol. 45, no. 2, pp. 117–123, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. D. J. Purcell, O. Khalid, C. Y. Ou et al., “Recruitment of coregulator G9a by RUNX2 for selective enhancement or suppression of transcription,” Journal of Cellular Biochemistry, vol. 113, no. 7, pp. 2406–2414, 2012. View at Google Scholar
  19. K. F. Underwood, D. R. D'Souza, M. Mochin-Peters et al., “Regulation of RUNX2 transcription factor-DNA interactions and cell proliferation by vitamin D3 (cholecalciferol) prohormone activity,” Journal of Bone and Mineral Research, vol. 27, pp. 913–925, 2012. View at Google Scholar
  20. K. N. Lee, W. G. Jang, E. J. Kim et al., “Orphan nuclear receptor COUP-TFII negatively regulates BMP2-induced osteoblast differentiation through suppressing RUNX2 activity,” The Journal of Biological Chemistry, vol. 287, no. 23, pp. 18888–18899, 2012. View at Google Scholar
  21. Y. Li, C. Ge, J. P. Long et al., “Biomechanical stimulation of osteoblast gene expression requires phosphorylation of the RUNX2 transcription factor,” Journal of Bone and Mineral Research, vol. 27, no. 6, pp. 1263–1274, 2012. View at Google Scholar
  22. E. S. Park, A. K. Lind, P. Dahm-Kähler et al., “RUNX2 transcription factor regulates gene expression in luteinizing granulosa cells of rat ovaries,” Molecular Endocrinology, vol. 24, no. 4, pp. 846–858, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. Tonomoto, M. Tachibana, D. K. Dhar et al., “Differential expression of RUNX genes in human esophageal squamous cell carcinoma: downregulation of RUNX3 worsens patient prognosis,” Oncology, vol. 73, no. 5-6, pp. 346–356, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. S. H. Lee, X. Che, J. H. Jeong et al., “Runx2 protein stabilizes hypoxia-inducible factor-1α through competition with von Hippel-Lindau protein (pVHL) and stimulates angiogenesis in growth plate hypertrophic chondrocytes,” The Journal of Biological Chemistry, vol. 287, pp. 14760–14771, 2012. View at Google Scholar
  25. K. Edvardsson, A. Ström, P. Jonsson, J. A. Gustafsson, and C. Williams, “Estrogen receptor β induces antiinflammatory and antitumorigenic networks in colon cancer cells,” Molecular Endocrinology, vol. 25, no. 6, pp. 969–979, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. N. S. Nevadunsky, J. S. Barbieri, J. Kwong et al., “RUNX3 protein is overexpressed in human epithelial ovarian cancer,” Gynecologic Oncology, vol. 112, no. 2, pp. 325–330, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. J. H. Jeong and J. Y. Choi, “Interrelationship of RUNX2 and estrogen pathway in skeletal tissues,” BMB Reports, vol. 44, pp. 613–618, 2011. View at Google Scholar
  28. Z. L. Duan, Z. L. Peng, and Z. H. Wang, “Expression and involved signal transduction pathway of autophagy gene Beclin 1 in epithelial ovarian cancer,” Sichuan Da Xue Xue Bao Yi Xue Ban, vol. 38, no. 2, pp. 239–242, 2007. View at Google Scholar · View at Scopus
  29. S. Chakrabarty and L. Kondratick, “Insulin-like growth factor binding protein-2 stimulates proliferation and activates multiple cascades of the mitogen-activated protein kinase pathways in NIH-OVCAR3 human epithelial ovarian cancer cells,” Cancer Biology and Therapy, vol. 5, no. 2, pp. 189–197, 2006. View at Google Scholar · View at Scopus